U.S. health officials are dealing with shortages and production delays of H1N1 vaccine, but stand by the choice not to opt for vaccine boosters, called adjuvants, that could stretch supply of H1N1 vaccine, but are not licensed in the United…
Support Provided By: Learn more
Educate your inbox
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.